MR imaging techniques for nano-pathophysiology and theranostics

Advanced Drug Delivery Reviews

Volumn 74, Issue , 2014, Pages 75-94

  Bennett, Kevin M ^a   Jo, Jun Ichiro ^b   Cabral, Horacio ^c   Bakalova, Rumiana ^b   Aoki, Ichio ^b  

^a The University of Hawaii at Manoa Department of Biology College of Natural Sciences ^*  (United States)

^b NATIONAL INSTITUTE OF RADIOLOGICAL SCIENCES   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

Author keywords

Activatable; Cancer; DDS; In vivo imaging; MRI; Multimodal; Nanoparticles; Theranostics

Indexed keywords

DISEASES; DRUG DELIVERY; NANOPARTICLES; IMAGING TECHNIQUES;

ACTIVATABLE; CANCER; DDS; IN-VIVO IMAGING; MULTI-MODAL; THERANOSTICS;

MAGNETIC RESONANCE IMAGING;

CARBON NANOTUBE; CISPLATIN; DENDRIMER; DEXTRAN; DOXORUBICIN; FIRTECAN; FULLERENE DERIVATIVE; GADOFOSVESET; GADOLINIUM CHELATE; GADOLINIUM PENTETATE; GADOTERIC ACID; GADOXETIC ACID; GRAPHENE; IOHEXOL; LIPOSOME; MACROGOL; MAGNETIC NANOPARTICLE; NANOPARTICLE; NUCLEAR MAGNETIC RESONANCE IMAGING AGENT; OXALIPLATIN; PACLITAXEL; PHOTOSENSITIZING AGENT; POLYGLACTIN; POLYLYSINE; POLYMER; POLYSACCHARIDE; QUANTUM DOT; SILICON DIOXIDE; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLE; UNINDEXED DRUG; CONTRAST MEDIUM; FLUORINE; FULLERENE; HUMAN SERUM ALBUMIN; MANGANESE;

CONTRAST ENHANCEMENT; DRUG ACCUMULATION; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG HALF LIFE; DRUG RELEASE; DRUG STRUCTURE; EMULSION; HUMAN; LIPOSOMAL DELIVERY; LIVER TUMOR; MICELLE; MULTIMODAL IMAGING; NANOENCAPSULATION; NANOTECHNOLOGY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PERSONALIZED MEDICINE; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; REVIEW; ANIMAL; DIAGNOSTIC USE; PROCEDURES; CONJUGATION; HYPERPOLARIZATION; MOLECULAR IMAGING; NANOPHARMACEUTICS; PARTICLE SIZE; PATHOPHYSIOLOGY; POLYMERIZATION; SYNTHESIS; THERANOSTIC NANOMEDICINE;

ANIMALS; CONTRAST MEDIA; DRUG DELIVERY SYSTEMS; HUMANS; MAGNETIC RESONANCE IMAGING; NANOPARTICLES; NANOTECHNOLOGY;

EID: 84906058983     PISSN: 0169409X     EISSN: 18728294     Source Type: Journal    
DOI: 10.1016/j.addr.2014.04.007     Document Type: Review

References (318)

1. Johnson G.A., Calabrese E., Badea A., Paxinos G., Watson C. A multidimensional magnetic resonance histology atlas of the Wistar rat brain. Neuroimage 2012, 62:1848-1856.
2. Matsumura Y., Maeda H. A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. Cancer Res. 1986, 46:6387-6392.
3. Papahadjopoulos D., Allen T.M., Gabizon A., Mayhew E., Matthay K., Huang S.K., Lee K.D., Woodle M.C., Lasic D.D., Redemann C., et al. Sterically stabilized liposomes: improvements in pharmacokinetics and antitumor therapeutic efficacy. Proc. Natl. Acad. Sci. U. S. A. 1991, 88:11460-11464.
4. Kano M.R., Bae Y., Iwata C., Morishita Y., Yashiro M., Oka M., Fujii T., Komuro A., Kiyono K., Kaminishi M., Hirakawa K., Ouchi Y., Nishiyama N., Kataoka K., Miyazono K. Improvement of cancer-targeting therapy, using nanocarriers for intractable solid tumors by inhibition of TGF-beta signaling. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:3460-3465.
5. Cabral H., Nishiyama N., Kataoka K. Supramolecular nanodevices: from design validation to theranostic nanomedicine. Acc. Chem. Res. 2011, 44:999-1008.
6. Bumb A., Brechbiel M.W., Choyke P. Macromolecular and dendrimer-based magnetic resonance contrast agents. Acta Radiol. 2010, 51:751-767.
7. Kataoka K., Harada A., Nagasaki Y. Block copolymer micelles for drug delivery: design, characterization and biological significance. Adv. Drug Deliv. Rev. 2001, 47:113-131.
8. Kaida S., Cabral H., Kumagai M., Kishimura A., Terada Y., Sekino M., Aoki I., Nishiyama N., Tani T., Kataoka K. Visible drug delivery by supramolecular nanocarriers directing to single-platformed diagnosis and therapy of pancreatic tumor model. Cancer Res. 2010, 70:7031-7041.
9. Kabalka G.W., Davis M.A., Moss T.H., Buonocore E., Hubner K., Holmberg E., Maruyama K., Huang L. Gadolinium-labeled liposomes containing various amphiphilic Gd-DTPA derivatives: targeted MRI contrast enhancement agents for the liver. Magn. Reson. Med. 1991, 19:406-415.
10. Ponce A.M., Viglianti B.L., Yu D., Yarmolenko P.S., Michelich C.R., Woo J., Bally M.B., Dewhirst M.W. Magnetic resonance imaging of temperature-sensitive liposome release: drug dose painting and antitumor effects. J. Natl. Cancer Inst. 2007, 99:53-63.
11. Kono K., Nakashima S., Kokuryo D., Aoki I., Shimomoto H., Aoshima S., Maruyama K., Yuba E., Kojima C., Harada A., Ishizaka Y. Multi-functional liposomes having temperature-triggered release and magnetic resonance imaging for tumor-specific chemotherapy. Biomaterials 2011, 32:1387-1395.
12. Mulder W.J., Strijkers G.J., van Tilborg G.A., Griffioen A.W., Nicolay K. Lipid-based nanoparticles for contrast-enhanced MRI and molecular imaging. NMR Biomed. 2006, 19:142-164.
13. Doiron A.L., Homan K.A., Emelianov S., Brannon-Peppas L. Poly(lactic-co-glycolic) acid as a carrier for imaging contrast agents. Pharm. Res. 2009, 26:674-682.
14. Margerum L.D., Campion B.K., Koo M., Shargill N., Lai J.J., Marumoto A., Sontum P.C. Gadolinium(III) DO3A macrocycles and polyethylene glycol coupled to dendrimers-effect of molecular weight on physical and biological properties of macromolecular magnetic resonance imaging contrast agents. J. Alloys Compd. 1997, 249:185-190.
15. Kobayashi H., Kawamoto S., Saga T., Sato N., Hiraga A., Ishimori T., Akita Y., Mamede M.H., Konishi J., Togashi K., Brechbiel M.W. Novel liver macromolecular MR contrast agent with a polypropylenimine diaminobutyl dendrimer core: comparison to the vascular MR contrast agent with the polyamidoamine dendrimer core. Magn. Reson. Med. 2001, 46:795-802.
16. Medintz I.L., Clapp A.R., Mattoussi H., Goldman E.R., Fisher B., Mauro J.M. Self-assembled nanoscale biosensors based on quantum dot FRET donors. Nat. Mater. 2003, 2:630-638.
17. Bakalova R., Zhelev Z., Aoki I., Ohba H., Imai Y., Kanno I. Silica-shelled single quantum dot micelles as imaging probes with dual or multimodality. Anal. Chem. 2006, 78:5925-5932.
18. Mikawa M., Kato H., Okumura M., Narazaki M., Kanazawa Y., Miwa N., Shinohara H. Paramagnetic water-soluble metallofullerenes having the highest relaxivity for MRI contrast agents. Bioconjug. Chem. 2001, 12:510-514.
19. 3+ ions for photodynamic therapy. J. Control. Release 2007, 117:104-110.
20. Bulte J.W., Hoekstra Y., Kamman R.L., Magin R.L., Webb A.G., Briggs R.W., Go K.G., Hulstaert C.E., Miltenyi S., The T.H., et al. Specific MR imaging of human lymphocytes by monoclonal antibody-guided dextran-magnetite particles. Magn. Reson. Med. 1992, 25:148-157.
21. Yeh T.C., Zhang W., Ildstad S.T., Ho C. In vivo dynamic MRI tracking of rat T-cells labeled with superparamagnetic iron-oxide particles. Magn. Reson. Med. 1995, 33:200-208.
22. Weissleder R., Elizondo G., Josephson L., Compton C.C., Fretz C.J., Stark D.D., Ferrucci J.T. Experimental lymph node metastases: enhanced detection with MR lymphography. Radiology 1989, 171:835-839.
23. Reimer P., Weissleder R., Lee A.S., Wittenberg J., Brady T.J. Receptor imaging: application to MR imaging of liver cancer. Radiology 1990, 177:729-734.
24. Viale A., Reineri F., Santelia D., Cerutti E., Ellena S., Gobetto R., Aime S. Hyperpolarized agents for advanced MRI investigations. Q. J. Nucl. Med. Mol. Imaging 2009, 53:604-617.
25. Gallagher F.A., Kettunen M.I., Day S.E., Hu D.E., Ardenkjaer-Larsen J.H., Zandt R., Jensen P.R., Karlsson M., Golman K., Lerche M.H., Brindle K.M. Magnetic resonance imaging of pH in vivo using hyperpolarized 13C-labelled bicarbonate. Nature 2008, 453:940-943.
26. Merritt M.E., Harrison C., Storey C., Jeffrey F.M., Sherry A.D., Malloy C.R. Hyperpolarized 13C allows a direct measure of flux through a single enzyme-catalyzed step by NMR. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:19773-19777.
27. Merritt M.E., Harrison C., Kovacs Z., Kshirsagar P., Malloy C.R., Sherry A.D. Hyperpolarized (89)Y offers the potential of direct imaging of metal ions in biological systems by magnetic resonance. J. Am. Chem. Soc. 2007, 129:12942-12943.
28. Atkins T.M., Cassidy M.C., Lee M., Ganguly S., Marcus C.M., Kauzlarich S.M. Synthesis of long T(1) silicon nanoparticles for hyperpolarized (2)(9)Si magnetic resonance imaging. ACS Nano 2013, 7:1609-1617.
29. Cassidy M.C., Chan H.R., Ross B.D., Bhattacharya P.K., Marcus C.M. In vivo magnetic resonance imaging of hyperpolarized silicon particles. Nat. Nanotechnol. 2013, 8:363-368.
30. Kim T., Momin E., Choi J., Yuan K., Zaidi H., Kim J., Park M., Lee N., McMahon M.T., Quinones-Hinojosa A., Bulte J.W., Hyeon T., Gilad A.A. Mesoporous silica-coated hollow manganese oxide nanoparticles as positive T1 contrast agents for labeling and MRI tracking of adipose-derived mesenchymal stem cells. J. Am. Chem. Soc. 2011, 133:2955-2961.
31. Braunecker W.A., Matyjaszewski K. Controlled/living radical polymerization: features, developments, and perspectives. Prog. Polym. Sci. 2007, 32:93-146.
32. Battistini E., Gianolio E., Gref R., Couvreur P., Fuzerova S., Othman M., Aime S., Badet B., Durand P. High-relaxivity magnetic resonance imaging (MRI) contrast agent based on supramolecular assembly between a gadolinium chelate, a modified dextran, and poly-beta-cyclodextrin. Chemistry 2008, 14:4551-4561.
33. Mikawa M., Miwa N., Brautigam M., Akaike T., Maruyama A. Gd(3+)-loaded polyion complex for pH depiction with magnetic resonance imaging. J. Biomed. Mater. Res. 2000, 49:390-395.
34. Luo K., Tian J., Liu G., Sun J., Xia C., Tang H., Lin L., Miao T., Zhao X., Gao F., Gong Q., Song B., Shuai X., Ai H., Gu Z. Self-assembly of SiO2/Gd-DTPA-polyethylenimine nanocomposites as magnetic resonance imaging probes. J. Nanosci. Nanotechnol. 2010, 10:540-548.
35. Villaraza A.J., Bumb A., Brechbiel M.W. Macromolecules, dendrimers, and nanomaterials in magnetic resonance imaging: the interplay between size, function, and pharmacokinetics. Chem. Rev. 2010, 110:2921-2959.
36. Peters T. Serum albumin. Adv. Clin. Chem. 1970, 13:37-111.
37. Moseley M.E., Chew W.M., White D.L., Kucharczyk J., Litt L., Derugin N., Dupon J., Brasch R.C., Norman D. Hypercarbia-induced changes in cerebral blood volume in the cat: a 1H MRI and intravascular contrast agent study. Magn. Reson. Med. 1992, 23:21-30.
38. Wikstrom M.G., Moseley M.E., White D.L., Dupon J.W., Winkelhake J.L., Kopplin J., Brasch R.C. Contrast-enhanced MRI of tumors. Comparison of Gd-DTPA and a macromolecular agent. Invest. Radiol. 1989, 24:609-615.
39. van Dijke C.F., Kirk B.A., Peterfy C.G., Genant H.K., Brasch R.C., Kapila S. Arthritic temporomandibular joint: correlation of macromolecular contrast-enhanced MR imaging parameters and histopathologic findings. Radiology 1997, 204:825-832.
40. Daldrup H., Shames D.M., Wendland M., Okuhata Y., Link T.M., Rosenau W., Lu Y., Brasch R.C. Correlation of dynamic contrast-enhanced MR imaging with histologic tumor grade: comparison of macromolecular and small-molecular contrast media. AJR Am. J. Roentgenol. 1998, 171:941-949.
41. Zhang Z., Nair S.A., McMurry T.J. Gadolinium meets medicinal chemistry: MRI contrast agent development. Curr. Med. Chem. 2005, 12:751-778.
42. Baxter A.B., Lazarus S.C., Brasch R.C. In vitro histamine release induced by magnetic resonance imaging and iodinated contrast media. Invest. Radiol. 1993, 28:308-312.
43. Muller R.N., Raduchel B., Laurent S., Platzek J., Pierart C., Mareski P., Vander Elst L. Physicochemical characterization of MS-325, a new gadolinium complex, by multinuclear relaxometry. Eur. J. Inorg. Chem. 1999, 1949-1955.
44. Hermanson G.T. Bioconjugate Techniques 1996, Academic Press.
45. Hnatowich D.J., Layne W.W., Childs R.L., Lanteigne D., Davis M.A., Griffin T.W., Doherty P.W. Radioactive labeling of antibody: a simple and efficient method. Science 1983, 220:613-615.
46. Shreve P., Aisen A.M. Monoclonal antibodies labeled with polymeric paramagnetic ion chelates. Magn. Reson. Med. 1986, 3:336-340.
47. Slinkin M.A., Curtet C., Faivre-Chauvet A., Sai-Maurel C., Gestin J.F., Torchilin V.P., Chatal J.F. Biodistribution of anti-CEA F(ab')2 fragments conjugated with chelating polymers: influence of conjugate electron charge on tumor uptake and blood clearance. Nucl. Med. Biol. 1993, 20:443-452.
48. Manabe Y., Longley C., Furmanski P. High-level conjugation of chelating agents onto immunoglobulins: use of an intermediary poly(l-lysine)-diethylenetriaminepentaacetic acid carrier. Biochim. Biophys. Acta 1986, 883:460-467.
49. Bernard E.D., Beking M.A., Rajamanickam K., Tsai E.C., Derosa M.C. Target binding improves relaxivity in aptamer-gadolinium conjugates. J. Biol. Inorg. Chem. 2012, 17:1159-1175.
50. Xu W., Lu Y. A smart magnetic resonance imaging contrast agent responsive to adenosine based on a DNA aptamer-conjugated gadolinium complex. Chem. Commun. (Camb.) 2011, 47:4998-5000.
51. Lim T.H., Lee D.H., Kim Y.H., Park S.W., Park P.H., Seo D.M., Kim S.T., Lee T.K., Mun C.W. Occlusive and reperfused myocardial infarction: detection by using MR imaging with gadolinium polylysine enhancement. Radiology 1993, 189:765-768.
52. Berthezene Y., Vexler V., Kuwatsuru R., Rosenau W., Muhler A., Clement O., Price D.C., Brasch R.C. Differentiation of alveolitis and pulmonary fibrosis with a macromolecular MR imaging contrast agent. Radiology 1992, 185:97-103.
53. Opsahl L.R., Uzgiris E.E., Vera D.R. Tumor imaging with a macromolecular paramagnetic contrast agent: gadopentetate dimeglumine-polylysine. Acad. Radiol. 1995, 2:762-767.
54. Yamaoka T., Tabata Y., Ikada Y. Body distribution profile of polysaccharide after intravenous administration. Drug Deliv. 1993, 1.
55. Kaneo Y., Tanaka T., Nakano T., Yamaguchi Y. Evidence for receptor-mediated hepatic uptake of pullulan in rats. J. Control. Release 2001, 70:365-373.
56. Tang C.K., Lodding J., Minigo G., Pouniotis D.S., Plebanski M., Scholzen A., McKenzie I.F., Pietersz G.A., Apostolopoulos V. Mannan-mediated gene delivery for cancer immunotherapy. Immunology 2007, 120:325-335.
57. Yadav A.K., Mishra P., Agrawal G.P. An insight on hyaluronic acid in drug targeting and drug delivery. J. Drug Target. 2008, 16:91-107.
58. Klotz U., Kroemer H. Clinical pharmacokinetic considerations in the use of plasma expanders. Clin. Pharmacokinet. 1987, 12:123-135.
59. Gibby W.A., Bogdan A., Ovitt T.W. Cross-linked DTPA polysaccharides for magnetic resonance imaging. Synthesis and relaxation properties. Invest. Radiol. 1989, 24:302-309.
60. Rongved P., Klaveness J. Water-soluble polysaccharides as carriers of paramagnetic contrast agents for magnetic resonance imaging: synthesis and relaxation properties. Carbohydr. Res. 1991, 214:315-323.
61. Loubeyre P., Canet E., Zhao S., Benderbous S., Amiel M., Revel D. Carboxymethyl-dextran-gadolinium-DTPA as a blood-pool contrast agent for magnetic resonance angiography. Experimental study in rabbits. Invest. Radiol. 1996, 31:288-293.
62. Jacobs R.E., Fraser S.E. Magnetic resonance microscopy of embryonic cell lineages and movements. Science 1994, 263:681-684.
63. Wikstrom M., Martinussen H.J., Wikstrom G., Ericsson A., Nyman R., Waldenstrom A., Hemmingsson A. MR imaging of acute myocardial infarction in pigs using Gd-DTPA-labeled dextran. Acta Radiol. 1992, 33:301-308.
64. Casali C., Janier M., Canet E., Obadia J.F., Benderbous S., Corot C., Revel D. Evaluation of Gd-DOTA-labeled dextran polymer as an intravascular MR contrast agent for myocardial perfusion. Acad. Radiol. 1998, 5(Suppl. 1):S214-S218.
65. Liu Y., Zhang N. Gadolinium loaded nanoparticles in theranostic magnetic resonance imaging. Biomaterials 2012, 33:5363-5375.
66. Lebduskova P., Kotek J., Hermann P., Vander Elst L., Muller R.N., Lukes I., Peters J.A. A gadolinium(III) complex of a carboxylic-phosphorus acid derivative of diethylenetriamine covalently bound to inulin, a potential macromolecular MRI contrast agent. Bioconjug. Chem. 2004, 15:881-889.
67. Helbich T.H., Gossman A., Mareski P.A., Raduchel B., Roberts T.P., Shames D.M., Muhler M., Turetschek K., Brasch R.C. A new polysaccharide macromolecular contrast agent for MR imaging: biodistribution and imaging characteristics. J. Magn. Reson. Imaging 2000, 11:694-701.
68. Cavagna F., Luchinat C., Scozzafava A., Xia Z. Polymetallic macromolecules are potential contrast agents of improved efficiency. Magn. Reson. Med. 1994, 31:58-60.
69. Allen M.J., Raines R.T., Kiessling L.L. Contrast agents for magnetic resonance imaging synthesized with ring-opening metathesis polymerization. J. Am. Chem. Soc. 2006, 128:6534-6535.
70. Wu Y., Zhou Y., Ouari O., Woods M., Zhao P., Soesbe T.C., Kiefer G.E., Sherry A.D. Polymeric PARACEST agents for enhancing MRI contrast sensitivity. J. Am. Chem. Soc. 2008, 130:13854-13855.
71. Langereis S., de Lussanet Q.G., van Genderen M.H.P., Backes W.H., Meijer E.W. Multivalent contrast agents based on gadolinium-diethylenetriaminepentaacetic acid-terminated poly(propylene imine) dendrimers for magnetic resonance imaging. Macromolecules 2004, 37:3084-3091.
72. Sato N., Kobayashi H., Hiraga A., Saga T., Togashi K., Konishi J., Brechbiel M.W. Pharmacokinetics and enhancement patterns of macromolecular MR contrast agents with various sizes of polyamidoamine dendrimer cores. Magn. Reson. Med. 2001, 46:1169-1173.
73. Kobayashi H., Sato N., Kawamoto S., Saga T., Hiraga A., Haque T.L., Ishimori T., Konishi J., Togashi K., Brechbiel M.W. Comparison of the macromolecular MR contrast agents with ethylenediamine-core versus ammonia-core generation-6 polyamidoamine dendrimer. Bioconjug. Chem. 2001, 12:100-107.
74. Huang Z., Sengar R.S., Nigam A., Abadjian M.C., Potter D.M., Grotjahn D.B., Wiener E.C. A fluorinated dendrimer-based nanotechnology platform: new contrast agents for high field imaging. Invest. Radiol. 2010, 45:641-654.
75. Thurecht K.J., Blakey I., Peng H., Squires O., Hsu S., Alexander C., Whittaker A.K. Functional hyperbranched polymers: toward targeted in vivo 19F magnetic resonance imaging using designed macromolecules. J. Am. Chem. Soc. 2010, 132:5336-5337.
76. Tan M., Ye Z., Jeong E.K., Wu X., Parker D.L., Lu Z.R. Synthesis and evaluation of nanoglobular macrocyclic Mn(II) chelate conjugates as non-gadolinium(III) MRI contrast agents. Bioconjug. Chem. 2011, 22:931-937.
77. Wu Y., Evbuomwan M., Melendez M., Opina A., Sherry A.D. Advantages of macromolecular to nanosized chemical-exchange saturation transfer agents for MRI applications. Future Med. Chem. 2010, 2:351-366.
78. Pikkemaat J.A., Wegh R.T., Lamerichs R., van de Molengraaf R.A., Langereis S., Burdinski D., Raymond A.Y., Janssen H.M., de Waal B.F., Willard N.P., Meijer E.W., Grull H. Dendritic PARACEST contrast agents for magnetic resonance imaging. Contrast Media Mol. Imaging 2007, 2:229-239.
79. Ali M.M., Yoo B., Pagel M.D. Tracking the relative in vivo pharmacokinetics of nanoparticles with PARACEST MRI. Mol. Pharm. 2009, 6:1409-1416.
80. Zarabi B., Nan A., Zhuo J., Gullapalli R., Ghandehari H. Macrophage targeted N-(2-hydroxypropyl)methacrylamide conjugates for magnetic resonance imaging. Mol. Pharm. 2006, 3:550-557.
81. Boswell C.A., Eck P.K., Regino C.A., Bernardo M., Wong K.J., Milenic D.E., Choyke P.L., Brechbiel M.W. Synthesis, characterization, and biological evaluation of integrin alphavbeta3-targeted PAMAM dendrimers. Mol. Pharm. 2008, 5:527-539.
82. Pike D.B., Ghandehari H. HPMA copolymer-cyclic RGD conjugates for tumor targeting. Adv. Drug Deliv. Rev. 2010, 62:167-183.
83. Han L., Li J., Huang S., Huang R., Liu S., Hu X., Yi P., Shan D., Wang X., Lei H., Jiang C. Peptide-conjugated polyamidoamine dendrimer as a nanoscale tumor-targeted T1 magnetic resonance imaging contrast agent. Biomaterials 2011, 32:2989-2998.
84. Luo K., Liu G., He B., Wu Y., Gong Q., Song B., Ai H., Gu Z. Multifunctional gadolinium-based dendritic macromolecules as liver targeting imaging probes. Biomaterials 2011, 32:2575-2585.
85. Pashkunova-Martic I., Kremser C., Galanski M., Schluga P., Arion V., Debbage P., Jaschke W., Keppler B. Lectin conjugates as biospecific contrast agents for MRI. Coupling of Lycopersicon esculentum agglutinin to linear water-soluble DTPA-loaded oligomers. Mol. Imaging Biol. 2011, 13:432-442.
86. Winalski C.S., Shortkroff S., Schneider E., Yoshioka H., Mulkern R.V., Rosen G.M. Targeted dendrimer-based contrast agents for articular cartilage assessment by MR imaging. Osteoarthritis Cartilage 2008, 16:815-822.
87. Jo J., Lin X., Nakahara T., Aoki I., Saga T., Tabata Y. Preparation of polymer-based magnetic resonance imaging contrast agent to visualize therapeutic angiogenesis. Tissue Eng. Part A 2013, 19:30-39.
88. Mohs A.M., Wang X., Goodrich K.C., Zong Y., Parker D.L., Lu Z.R. PEG-g-poly(GdDTPA-co-l-cystine): a biodegradable macromolecular blood pool contrast agent for MR imaging. Bioconjug. Chem. 2004, 15:1424-1430.
89. Lu Z.R., Wang X., Parker D.L., Goodrich K.C., Buswell H.R. Poly(l-glutamic acid) Gd(III)-DOTA conjugate with a degradable spacer for magnetic resonance imaging. Bioconjug. Chem. 2003, 14:715-719.
90. Huang C.H., Nwe K., Al Zaki A., Brechbiel M.W., Tsourkas A. Biodegradable polydisulfide dendrimer nanoclusters as MRI contrast agents. ACS Nano 2012, 6:9416-9424.
91. Ye M., Qian Y., Tang J., Hu H., Sui M., Shen Y. Targeted biodegradable dendritic MRI contrast agent for enhanced tumor imaging. J. Control. Release 2013, 169:239-245.
92. Ali M.M., Woods M., Caravan P., Opina A.C., Spiller M., Fettinger J.C., Sherry A.D. Synthesis and relaxometric studies of a dendrimer-based pH-responsive MRI contrast agent. Chemistry 2008, 14:7250-7258.
93. Okada S., Mizukami S., Kikuchi K. Switchable MRI contrast agents based on morphological changes of pH-responsive polymers. Bioorg. Med. Chem. 2012, 20:769-774.
94. Ju S., Qiu Y., Li C., Teng G.J., Ni Y. Multimodality imaging of endothelial progenitor cells with a novel multifunctional probe featuring positive magnetic resonance contrast and near-infrared fluorescence. Mol. Imaging 2011, 10:359-369.
95. Wen S., Li K., Cai H., Chen Q., Shen M., Huang Y., Peng C., Hou W., Zhu M., Zhang G., Shi X. Multifunctional dendrimer-entrapped gold nanoparticles for dual mode CT/MR imaging applications. Biomaterials 2013, 34:1570-1580.
96. Zarabi B., Nan A., Zhuo J., Gullapalli R., Ghandehari H. HPMA copolymer-doxorubicin-gadolinium conjugates: synthesis, characterization, and in vitro evaluation. Macromol. Biosci. 2008, 8:741-748.
97. Bryson J.M., Fichter K.M., Chu W.J., Lee J.H., Li J., Madsen L.A., McLendon P.M., Reineke T.M. Polymer beacons for luminescence and magnetic resonance imaging of DNA delivery. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:16913-16918.
98. Gianella A., Jarzyna P.A., Mani V., Ramachandran S., Calcagno C., Tang J., Kann B., Dijk W.J., Thijssen V.L., Griffioen A.W., Storm G., Fayad Z.A., Mulder W.J. Multifunctional nanoemulsion platform for imaging guided therapy evaluated in experimental cancer. ACS Nano 2011, 5:4422-4433.
99. Yoo D., Lee J.H., Shin T.H., Cheon J. Theranostic magnetic nanoparticles. Acc. Chem. Res. 2011, 44:863-874.
100. Cormode D.P., Skajaa T., van Schooneveld M.M., Koole R., Jarzyna P., Lobatto M.E., Calcagno C., Barazza A., Gordon R.E., Zanzonico P., Fisher E.A., Fayad Z.A., Mulder W.J. Nanocrystal core high-density lipoproteins: a multimodality contrast agent platform. Nano Lett. 2008, 8:3715-3723.
101. Jordan V.C., Kodibagkar V.D., Beeman S.C., Hann B.D., Bennett K.M. Principles and emerging applications of nanomagnetic materials in medicine. Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol. 2012, 4:345-365.
102. Krishnan K.M. Biomedical nanomagnetics: a spin through possibilities in imaging. Diagn. Ther. IEEE Trans. Magn. 2010, 46:2523-2558.
103. Lam C., Zhang Y.F., Tang Y.H., Lee C.S., Bello I., Lee S.T. Large-scale synthesis of ultrafine Si nanoparticles by ball milling. J. Cryst. Growth 2000, 220:466-470.
104. Hyeon T. Chemical synthesis of magnetic nanoparticles. Chem. Commun. (Camb.) 2003, 927-934.
105. Lang C., Schuler D., Faivre D. Synthesis of magnetite nanoparticles for bio- and nanotechnology: genetic engineering and biomimetics of bacterial magnetosomes. Macromol. Biosci. 2007, 7:144-151.
106. Lin X.M., Samia A.C.S. Synthesis, assembly and physical properties of magnetic nanoparticles. J. Magn. Magn. Mater. 2006, 305:100-109.
107. Bennewitz M.F., Lobo T.L., Nkansah M.K., Ulas G., Brudvig G.W., Shapiro E.M. Biocompatible and pH-sensitive PLGA encapsulated MnO nanocrystals for molecular and cellular MRI. ACS Nano 2011, 5:3438-3446.
108. Engberink R.D., van der Pol S.M., Walczak P., van der Toorn A., Viergever M.A., Dijkstra C.D., Bulte J.W., de Vries H.E., Blezer E.L. Magnetic resonance imaging of monocytes labeled with ultrasmall superparamagnetic particles of iron oxide using magnetoelectroporation in an animal model of multiple sclerosis. Mol. Imaging 2010, 9:268-277.
109. Gilad A.A., Walczak P., McMahon M.T., Na H.B., Lee J.H., An K., Hyeon T., van Zijl P.C., Bulte J.W. MR tracking of transplanted cells with "positive contrast" using manganese oxide nanoparticles. Magn. Reson. Med. 2008, 60:1-7.
110. Huang G., Chen H., Dong Y., Luo X., Yu H., Moore Z., Bey E.A., Boothman D.A., Gao J. Superparamagnetic iron oxide nanoparticles: amplifying ROS stress to improve anticancer drug efficacy. Theranostics 2013, 3:116-126.
111. Laurent S., Bridot J.L., Elst L.V., Muller R.N. Magnetic iron oxide nanoparticles for biomedical applications. Future Med. Chem. 2010, 2:427-449.
112. Shapiro E.M., Skrtic S., Sharer K., Hill J.M., Dunbar C.E., Koretsky A.P. MRI detection of single particles for cellular imaging. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:10901-10906.
113. Tromsdorf U.I., Bigall N.C., Kaul M.G., Bruns O.T., Nikolic M.S., Mollwitz B., Sperling R.A., Reimer R., Hohenberg H., Parak W.J., Forster S., Beisiegel U., Adam G., Weller H. Size and surface effects on the MRI relaxivity of manganese ferrite nanoparticle contrast agents. Nano Lett. 2007, 7:2422-2427.
114. Yigit M.V., Moore A., Medarova Z. Magnetic nanoparticles for cancer diagnosis and therapy. Pharm. Res. 2012, 29:1180-1188.
115. von zur Muhlen C., von Elverfeldt D., Moeller J.A., Choudhury R.P., Paul D., Hagemeyer C.E., Olschewski M., Becker A., Neudorfer I., Bassler N., Schwarz M., Bode C., Peter K. Magnetic resonance imaging contrast agent targeted toward activated platelets allows in vivo detection of thrombosis and monitoring of thrombolysis. Circulation 2008, 118:258-267.
116. Granot D., Shapiro E.M. Release activation of iron oxide nanoparticles: (REACTION) a novel environmentally sensitive MRI paradigm. Magn. Reson. Med. 2011, 65:1253-1259.
117. Cormode D.P., Jarzyna P.A., Mulder W.J., Fayad Z.A. Modified natural nanoparticles as contrast agents for medical imaging. Adv. Drug Deliv. Rev. 2010, 62:329-338.
118. Kaiser C.R., Flenniken M.L., Gillitzer E., Harmsen A.L., Harmsen A.G., Jutila M.A., Douglas T., Young M.J. Biodistribution studies of protein cage nanoparticles demonstrate broad tissue distribution and rapid clearance in vivo. Int. J. Nanomedicine 2007, 2:715-733.
119. Zurkiya O., Chan A.W., Hu X. MagA is sufficient for producing magnetic nanoparticles in mammalian cells, making it an MRI reporter. Magn. Reson. Med. 2008, 59:1225-1231.
120. Bulte J.W., Douglas T., Mann S., Frankel R.B., Moskowitz B.M., Brooks R.A., Baumgarner C.D., Vymazal J., Strub M.P., Frank J.A. Magnetoferritin: characterization of a novel superparamagnetic MR contrast agent. J. Magn. Reson. Imaging 1994, 4:497-505.
121. Cohen B., Dafni H., Meir G., Harmelin A., Neeman M. Ferritin as an endogenous MRI reporter for noninvasive imaging of gene expression in C6 glioma tumors. Neoplasia 2005, 7:109-117.
122. Iordanova B., Robison C.S., Ahrens E.T. Design and characterization of a chimeric ferritin with enhanced iron loading and transverse NMR relaxation rate. J. Biol. Inorg. Chem. 2010, 15:957-965.
123. Jordan V.C., Caplan M.R., Bennett K.M. Simplified synthesis and relaxometry of magnetoferritin for magnetic resonance imaging. Magn. Reson. Med. 2010, 64:1260-1266.
124. Doiron A.L., Chu K., Ali A., Brannon-Peppas L. Preparation and initial characterization of biodegradable particles containing gadolinium-DTPA contrast agent for enhanced MRI. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:17232-17237.
125. Granot D., Nkansah M.K., Bennewitz M.F., Tang K.S., Markakis E.A., Shapiro E.M. Clinically viable magnetic poly(lactide-co-glycolide) particles for MRI-based cell tracking. Magn. Reson. Med. 2014, 71:1238-1250.
126. Nkansah M.K., Thakral D., Shapiro E.M. Magnetic poly(lactide-co-glycolide) and cellulose particles for MRI-based cell tracking. Magn. Reson. Med. 2011, 65:1776-1785.
127. Modo M., Kolosnjaj-Tabi J., Nicholls F., Ling W., Wilhelm C., Debarge O., Gazeau F., Clement O. Considerations for the clinical use of contrast agents for cellular MRI in regenerative medicine. Contrast Media Mol. Imaging 2013, 8:439-455.
128. Pinaud F., Michalet X., Bentolila L.A., Tsay J.M., Doose S., Li J.J., Iyer G., Weiss S. Advances in fluorescence imaging with quantum dot bio-probes. Biomaterials 2006, 27:1679-1687.
129. Jiang D., Wang L., Jiang W. Quantitative detection of antibody based on single-molecule counting by total internal reflection fluorescence microscopy with quantum dot labeling. Anal. Chim. Acta. 2009, 634:83-88.
130. Barth M., Schuster R., Gruber A., Cichos F. Imaging single quantum dots in three-dimensional photonic crystals. Phys. Rev. Lett. 2006, 96:243902.
131. Liu D.S., Phipps W.S., Loh K.H., Howarth M., Ting A.Y. Quantum dot targeting with lipoic acid ligase and HaloTag for single-molecule imaging on living cells. ACS Nano 2012, 6:11080-11087.
132. Bakalova R., Zhelev Z., Kokuryo D., Spasov L., Aoki I., Saga T. Chemical nature and structure of organic coating of quantum dots is crucial for their application in imaging diagnostics. Int. J. Nanomedicine 2011, 6:1719-1732.
133. Cassette E., Helle M., Bezdetnaya L., Marchal F., Dubertret B., Pons T. Design of new quantum dot materials for deep tissue infrared imaging. Adv. Drug Deliv. Rev. 2013, 65:719-731.
134. De M., Chou S.S., Joshi H.M., Dravid V.P. Hybrid magnetic nanostructures (MNS) for magnetic resonance imaging applications. Adv. Drug Deliv. Rev. 2011, 63:1282-1299.
135. Koole R., Mulder W.J., van Schooneveld M.M., Strijkers G.J., Meijerink A., Nicolay K. Magnetic quantum dots for multimodal imaging. Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol. 2009, 1:475-491.
136. Bakalova R., Zhelev Z., Aoki I., Kanno I. Designing quantum dot probes. Nat. Photonics 2007, 1:487-489.
137. Stasiuk G.J., Tamang S., Imbert D., Gateau C., Reiss P., Fries P., Mazzanti M. Optimizing the relaxivity of Gd(iii) complexes appended to InP/ZnS quantum dots by linker tuning. Dalton Trans. 2013, 42:8197-8200.
138. Cormode D.P., Sanchez-Gaytan B.L., Mieszawska A.J., Fayad Z.A., Mulder W.J. Inorganic nanocrystals as contrast agents in MRI: synthesis, coating and introduction of multifunctionality. NMR Biomed. 2013, 26:766-780.
139. Wang G., Su X. The synthesis and bio-applications of magnetic and fluorescent bifunctional composite nanoparticles. Analyst 2011, 136:1783-1798.
140. Mulder W.J., Strijkers G.J., Nicolay K., Griffioen A.W. Quantum dots for multimodal molecular imaging of angiogenesis. Angiogenesis 2010, 13:131-134.
141. Medintz I.L., Mattoussi H., Clapp A.R. Potential clinical applications of quantum dots. Int. J. Nanomedicine 2008, 3:151-167.
142. Singh S.P. Multifunctional magnetic quantum dots for cancer theranostics. J. Biomed. Nanotechnol. 2011, 7:95-97.
143. Ding H., Wu F. Image guided biodistribution of drugs and drug delivery. Theranostics 2012, 2:1037-1039.
144. Frohlich E. The role of surface charge in cellular uptake and cytotoxicity of medical nanoparticles. Int. J. Nanomedicine 2012, 7:5577-5591.
145. Chen N., He Y., Su Y., Li X., Huang Q., Wang H., Zhang X., Tai R., Fan C. The cytotoxicity of cadmium-based quantum dots. Biomaterials 2012, 33:1238-1244.
146. Zhao F., Zhao Y., Liu Y., Chang X., Chen C., Zhao Y. Cellular uptake, intracellular trafficking, and cytotoxicity of nanomaterials. Small 2011, 7:1322-1337.
147. Bakalova R., Ohba H., Zhelev Z., Ishikawa M., Baba Y. Quantum dots as photosensitizers?. Nat. Biotechnol. 2004, 22:1360-1361.
148. Luo G., Long J., Zhang B., Liu C., Ji S., Xu J., Yu X., Ni Q. Quantum dots in cancer therapy. Expert Opin. Drug Deliv. 2012, 9:47-58.
149. Yaghini E., Seifalian A.M., MacRobert A.J. Quantum dots and their potential biomedical applications in photosensitization for photodynamic therapy. Nanomedicine (Lond) 2009, 4:353-363.
150. Chatterjee D.K., Fong L.S., Zhang Y. Nanoparticles in photodynamic therapy: an emerging paradigm. Adv. Drug Deliv. Rev. 2008, 60:1627-1637.
151. Juzenas P., Chen W., Sun Y.P., Coelho M.A., Generalov R., Generalova N., Christensen I.L. Quantum dots and nanoparticles for photodynamic and radiation therapies of cancer. Adv. Drug Deliv. Rev. 2008, 60:1600-1614.
152. Iga A.M., Robertson J.H., Winslet M.C., Seifalian A.M. Clinical potential of quantum dots. J. Biomed. Biotechnol. 2007, 2007:76087.
153. Koide A., Kishimura A., Osada K., Jang W.D., Yamasaki Y., Kataoka K. Semipermeable polymer vesicle (PICsome) self-assembled in aqueous medium from a pair of oppositely charged block copolymers: physiologically stable micro-/nanocontainers of water-soluble macromolecules. J. Am. Chem. Soc. 2006, 128:5988-5989.
154. Lee S.J., Lee H.J., Moon M.J., Vu-Quang H., Muthiah M., Che H.L., Heo S.U., Jeong H.J., Jeong Y.Y., Park I.K. Superparamagnetic iron oxide nanoparticles-loaded polymersome-mediated gene delivery guided by enhanced magnetic resonance signal. J. Nanosci. Nanotechnol. 2011, 11:7057-7060.
155. Cheng Z.L., Thorek D.L.J., Tsourkas A. Porous polymersomes with encapsulated Gd-labeled dendrimers as highly efficient MRI contrast agents. Adv. Funct. Mater. 2009, 19:3753-3759.
156. Kokuryo D., Anraku Y., Kishimura A., Tanaka S., Kano M.R., Kershaw J., Nishiyama N., Saga T., Aoki I., Kataoka K. SPIO-PICsome: development of a highly sensitive and stealth-capable MRI nano-agent for tumor detection using SPIO-loaded unilamellar polyion complex vesicles (PICsomes). J. Control. Release 2013, 169:220-227.
157. Felber A.E., Dufresne M.H., Leroux J.C. pH-sensitive vesicles, polymeric micelles, and nanospheres prepared with polycarboxylates. Adv. Drug Deliv. Rev. 2012, 64:979-992.
158. Karanth H., Murthy R.S. pH-sensitive liposomes-principle and application in cancer therapy. J. Pharm. Pharmacol. 2007, 59:469-483.
159. Kono K. Thermosensitive polymer-modified liposomes. Adv. Drug Deliv. Rev. 2001, 53:307-319.
160. Wang J.Y., Wu Q.F., Li J.P., Ren Q.S., Wang Y.L., Liu X.M. Photo-sensitive liposomes: chemistry and application in drug delivery. Mini Rev. Med. Chem. 2010, 10:172-181.
161. Schroeder A., Kost J., Barenholz Y. Ultrasound, liposomes, and drug delivery: principles for using ultrasound to control the release of drugs from liposomes. Chem. Phys. Lipids 2009, 162:1-16.
162. Huang S.L. Liposomes in ultrasonic drug and gene delivery. Adv. Drug Deliv. Rev. 2008, 60:1167-1176.
163. Tilcock C., Ahkong Q.F., Koenig S.H., Brown R.D., Davis M., Kabalka G. The design of liposomal paramagnetic Mr agents-effect of vesicle size upon the relaxivity of surface-incorporated lipophilic chelates. Magn. Reson. Med. 1992, 27:44-51.
164. Bertini I., Bianchini F., Calorini L., Colagrande S., Fragai M., Franchi A., Gallo O., Gavazzi C., Luchinat C. Persistent contrast enhancement by sterically stabilized paramagnetic liposomes in murine melanoma. Magn. Reson. Med. 2004, 52:669-672.
165. Ayyagari A.L., Zhang X.D., Ghaghada K.B., Annapragada A., Hu X.P., Bellamkonda R.V. Long-circulating liposomal contrast agents for magnetic resonance imaging. Magn. Reson. Med. 2006, 55:1023-1029.
166. Unger E.C., Fritz T.A., Tilcock C., New T.E. Clearance of liposomal gadolinium: in vivo decomplexation. J. Magn. Reson. Imaging 1991, 1:689-693.
167. Jain R.K., Stylianopoulos T. Delivering nanomedicine to solid tumors. Nat. Rev. Clin. Oncol. 2010, 7:653-664.
168. Torchilin V. Multifunctional and stimuli-sensitive pharmaceutical nanocarriers. Eur. J. Pharm. Biopharm. 2009, 71:431-444.
169. Mulder W.J., Strijkers G.J., Griffioen A.W., van Bloois L., Molema G., Storm G., Koning G.A., Nicolay K. A liposomal system for contrast-enhanced magnetic resonance imaging of molecular targets. Bioconjug. Chem. 2004, 15:799-806.
170. Barkhausen J., Ebert W., Heyer C., Debatin J.F., Weinmann H.J. Detection of atherosclerotic plaque with Gadofluorine-enhanced magnetic resonance imaging. Circulation 2003, 108:605-609.
171. Zhang D., Feng X.Y., Henning T.D., Wen L., Lu W.Y., Pan H., Wu X., Zou L.G. MR imaging of tumor angiogenesis using sterically stabilized Gd-DTPA liposomes targeted to CD105. Eur. J. Radiol. 2009, 70:180-189.
172. Kluza E., Yeo S.Y., Schmid S., van der Schaft D.W., Boekhoven R.W., Schiffelers R.M., Storm G., Strijkers G.J., Nicolay K. Anti-tumor activity of liposomal glucocorticoids: the relevance of liposome-mediated drug delivery, intratumoral localization and systemic activity. J. Control. Release 2011, 151:10-17.
173. Erdogan S., Medarova Z.O., Roby A., Moore A., Torchilin V.P. Enhanced tumor MR imaging with gadolinium-loaded polychelating polymer-containing tumor-targeted liposomes. J. Magn. Reson. Imaging 2008, 27:574-580.
174. Maiseyeu A., Mihai G., Kampfrath T., Simonetti O.P., Sen C.K., Roy S., Rajagopalan S., Parthasarathy S. Gadolinium-containing phosphatidylserine liposomes for molecular imaging of atherosclerosis. J. Lipid Res. 2009, 50:2157-2163.
175. Paulis L.E., Jacobs I., van den Akker N.M., Geelen T., Molin D.G., Starmans L.W., Nicolay K., Strijkers G.J. Targeting of ICAM-1 on vascular endothelium under static and shear stress conditions using a liposomal Gd-based MRI contrast agent. J. Nanobiotechnol. 2012, 10:25.
176. Gianolio E., Porto S., Napolitano R., Baroni S., Giovenzana G.B., Aime S. Relaxometric investigations and MRI evaluation of a liposome-loaded pH-responsive gadolinium(III) complex. Inorg. Chem. 2012, 51:7210-7217.
177. Glogard C., Stensrud G., Aime S. Novel radical-responsive MRI contrast agent based on paramagnetic liposomes. Magn. Reson. Chem. 2003, 41:585-588.
178. Lokling K.E., Fossheim S.L., Klaveness J., Skurtveit R. Biodistribution of pH-responsive liposomes for MRI and a novel approach to improve the pH-responsiveness. J. Control. Release 2004, 98:87-95.
179. Perche F., Torchilin V.P. Recent trends in multifunctional liposomal nanocarriers for enhanced tumor targeting. J. Drug Deliv. 2013, 2013:705265.
180. Mitchell N., Kalber T.L., Cooper M.S., Sunassee K., Chalker S.L., Shaw K.P., Ordidge K.L., Badar A., Janes S.M., Blower P.J., Lythgoe M.F., Hailes H.C., Tabor A.B. Incorporation of paramagnetic, fluorescent and PET/SPECT contrast agents into liposomes for multimodal imaging. Biomaterials 2013, 34:1179-1192.
181. Zheng J., Liu J., Dunne M., Jaffray D.A., Allen C. In vivo performance of a liposomal vascular contrast agent for CT and MR-based image guidance applications. Pharm. Res. 2007, 24:1193-1201.
182. Li S., Goins B., Zhang L., Bao A. Novel multifunctional theranostic liposome drug delivery system: construction, characterization, and multimodality MR, near-infrared fluorescent, and nuclear imaging. Bioconjug. Chem. 2012, 23:1322-1332.
183. Negussie A.H., Yarmolenko P.S., Partanen A., Ranjan A., Jacobs G., Woods D., Bryant H., Thomasson D., Dewhirst M.W., Wood B.J., Dreher M.R. Formulation and characterisation of magnetic resonance imageable thermally sensitive liposomes for use with magnetic resonance-guided high intensity focused ultrasound. Int. J. Hyperthermia 2011, 27:140-155.
184. Ranjan A., Jacobs G.C., Woods D.L., Negussie A.H., Partanen A., Yarmolenko P.S., Gacchina C.E., Sharma K.V., Frenkel V., Wood B.J., Dreher M.R. Image-guided drug delivery with magnetic resonance guided high intensity focused ultrasound and temperature sensitive liposomes in a rabbit Vx2 tumor model. J. Control. Release 2012, 158:487-494.
185. Nishiyama N., Kataoka K. Current state, achievements, and future prospects of polymeric micelles as nanocarriers for drug and gene delivery. Pharmacol. Ther. 2006, 112:630-648.
186. Osada K., Christie R.J., Kataoka K. Polymeric micelles from poly(ethylene glycol)-poly(amino acid) block copolymer for drug and gene delivery. J. R. Soc. Interface 2009, 6(Suppl. 3):S325-S339.
187. Nishiyama N., Kataoka K. Polymeric micelle drug carrier systems: PEG-PAsp(Dox) and second generation of micellar drugs. Adv. Exp. Med. Biol. 2003, 519:155-177.
188. Nishiyama N., Okazaki S., Cabral H., Miyamoto M., Kato Y., Sugiyama Y., Nishio K., Matsumura Y., Kataoka K. Novel cisplatin-incorporated polymeric micelles can eradicate solid tumors in mice. Cancer Res. 2003, 63:8977-8983.
189. Cabral H., Nishiyama N., Okazaki S., Koyama H., Kataoka K. Preparation and biological properties of dichloro(1,2-diaminocyclohexane)platinum(II) (DACHPt)-loaded polymeric micelles. J. Control. Release 2005, 101:223-232.
190. Itaka K., Kataoka K. Progress and prospects of polyplex nanomicelles for plasmid DNA delivery. Curr. Gene Ther. 2011, 11:457-465.
191. Allen T.M. Ligand-targeted therapeutics in anticancer therapy. Nat. Rev. Cancer 2002, 2:750-763.
192. Torchilin V.P., Lukyanov A.N., Gao Z., Papahadjopoulos-Sternberg B. Immunomicelles: targeted pharmaceutical carriers for poorly soluble drugs. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:6039-6044.
193. Jin C., Qian N., Zhao W., Yang W., Bai L., Wu H., Wang M., Song W., Dou K. Improved therapeutic effect of DOX-PLGA-PEG micelles decorated with bivalent fragment HAb18 F(ab')(2) for hepatocellular carcinoma. Biomacromolecules 2010, 11:2422-2431.
194. Farokhzad O.C., Cheng J., Teply B.A., Sherifi I., Jon S., Kantoff P.W., Richie J.P., Langer R. Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:6315-6320.
195. Zhang X.X., Eden H.S., Chen X. Peptides in cancer nanomedicine: drug carriers, targeting ligands and protease substrates. J. Control. Release 2012, 159:2-13.
196. Oba M., Vachutinsky Y., Miyata K., Kano M.R., Ikeda S., Nishiyama N., Itaka K., Miyazono K., Koyama H., Kataoka K. Antiangiogenic gene therapy of solid tumor by systemic injection of polyplex micelles loading plasmid DNA encoding soluble flt-1. Mol. Pharm. 2010, 7:501-509.
197. Bae Y., Jang W.D., Nishiyama N., Fukushima S., Kataoka K. Multifunctional polymeric micelles with folate-mediated cancer cell targeting and pH-triggered drug releasing properties for active intracellular drug delivery. Mol. Biosyst. 2005, 1:242-250.
198. Gohy J.F., Zhao Y. Photo-responsive block copolymer micelles: design and behavior. Chem. Soc. Rev. 2013, 42:7117-7129.
199. Rapoport N. Ultrasound-mediated micellar drug delivery. Int. J. Hyperthermia 2012, 28:374-385.
200. Matsumura Y., Kataoka K. Preclinical and clinical studies of anticancer agent-incorporating polymer micelles. Cancer Sci. 2009, 100:572-579.
201. Plummer R., Wilson R.H., Calvert H., Boddy A.V., Griffin M., Sludden J., Tilby M.J., Eatock M., Pearson D.G., Ottley C.J., Matsumura Y., Kataoka K., Nishiya T. A Phase I clinical study of cisplatin-incorporated polymeric micelles (NC-6004) in patients with solid tumours. Br. J. Cancer 2011, 104:593-598.
202. Trubetskoy V.S. Polymeric micelles as carriers of diagnostic agents. Adv. Drug Deliv. Rev. 1999, 37:81-88.
203. Torchilin V.P. PEG-based micelles as carriers of contrast agents for different imaging modalities. Adv. Drug Deliv. Rev. 2002, 54:235-252.
204. Lee H.Y., Jee H.W., Seo S.M., Kwak B.K., Khang G., Cho S.H. Diethylenetriaminepentaacetic acid-gadolinium (DTPA-Gd)-conjugated polysuccinimide derivatives as magnetic resonance imaging contrast agents. Bioconjug. Chem. 2006, 17:700-706.
205. Mok H., Zhang M. Superparamagnetic iron oxide nanoparticle-based delivery systems for biotherapeutics. Expert Opin. Drug Deliv. 2013, 10:73-87.
206. Bryson J., Reineke J.W., Reineke T.M. Macromolecular imaging agents containing lanthanides: can conceptual promise lead to clinical potential?. Macromolecules 2012, 45:8939-8952.
207. Zhang G., Zhang R., Wen X., Li L., Li C. Micelles based on biodegradable poly(l-glutamic acid)-b-polylactide with paramagnetic Gd ions chelated to the shell layer as a potential nanoscale MRI-visible delivery system. Biomacromolecules 2008, 9:36-42.
208. Antonella Accardo A., Tesauro D., Morelli G., Gianolio E., Aime S., Vaccaro M., Mangiapia G., Paduano L., Schillén K. Supramolecular aggregates containing lipophilic Gd(III) complexes as contrast agents in MRI. Coord. Chem. Rev. 2009, 253:2193-2213.
209. Nakamura E., Makino K., Okano T., Yamamoto T., Yokoyama M. A polymeric micelle MRI contrast agent with changeable relaxivity. J. Control. Release 2006, 114:325-333.
210. Shiraishi K., Kawano K., Maitani Y., Yokoyama M. Polyion complex micelle MRI contrast agents from poly(ethylene glycol)-b-poly(l-lysine) block copolymers having Gd-DOTA; preparations and their control of T(1)-relaxivities and blood circulation characteristics. J. Control. Release 2010, 148:160-167.
211. Idee J.M., Port M., Raynal I., Schaefer M., Le Greneur S., Corot C. Clinical and biological consequences of transmetallation induced by contrast agents for magnetic resonance imaging: a review. Fundam. Clin. Pharmacol. 2006, 20:563-576.
212. Kimura J., Ishiguchi T., Matsuda J., Ohno R., Nakamura A., Kamei S., Ohno K., Kawamura T., Murata K. Human comparative study of zinc and copper excretion via urine after administration of magnetic resonance imaging contrast agents. Radiat. Med. 2005, 23:322-326.
213. Puttagunta N.R., Gibby W.A., Smith G.T. Human in vivo comparative study of zinc and copper transmetallation after administration of magnetic resonance imaging contrast agents. Invest. Radiol. 1996, 31:739-742.
214. Anelli P.L., Lattuada L., Lorusso V., Schneider M., Tournier H., Uggeri F. Mixed micelles containing lipophilic gadolinium complexes as MRA contrast agents. MAGMA 2001, 12:114-120.
215. Tournier H., Hyacinthe R., Schneider M. Gadolinium-containing mixed micelle formulations: a new class of blood pool MRI/MRA contrast agents. Acad. Radiol. 2002, 9(Suppl. 1):S20-S28.
216. Trubetskoy V.S., Frank-Kamenetsky M.D., Whiteman K.R., Wolf G.L., Torchilin V.P. Stable polymeric micelles: lymphangiographic contrast media for gamma scintigraphy and magnetic resonance imaging. Acad. Radiol. 1996, 3:232-238.
217. Mi P., Cabral H., Kokuryo D., Rafi M., Terada Y., Aoki I., Saga T., Takehiko I., Nishiyama N., Kataoka K. Gd-DTPA-loaded polymer-metal complex micelles with high relaxivity for MR cancer imaging. Biomaterials 2013, 34:492-500.
218. Silva A.C., Lee J.H., Aoki I., Koretsky A.P. Manganese-enhanced magnetic resonance imaging (MEMRI): methodological and practical considerations. NMR Biomed. 2004, 17:532-543.
219. Choi K., Lee D.H., Jang W.D. Supramolecular micelle from amphiphilic Mn(III)-porphyrin derivatives as a potential MRI contrast agent. Bull. Korean Chem. Soc. 2010, 31:639-644.
220. Kumagai M., Imai Y., Nakamura T., Yamasaki Y., Sekino M., Ueno S., Hanaoka K., Kikuchi K., Nagano T., Kaneko E., Shimokado K., Kataoka K. Iron hydroxide nanoparticles coated with poly(ethylene glycol)-poly(aspartic acid) block copolymer as novel magnetic resonance contrast agents for in vivo cancer imaging. Colloids Surf. B: Biointerfaces 2007, 56:174-181.
221. Kumagai M., Kano M.R., Morishita Y., Ota M., Imai Y., Nishiyama N., Sekino M., Ueno S., Miyazono K., Kataoka K. Enhanced magnetic resonance imaging of experimental pancreatic tumor in vivo by block copolymer-coated magnetite nanoparticles with TGF-beta inhibitor. J. Control. Release 2009, 140:306-311.
222. Talelli M., Rijcken C.J., Lammers T., Seevinck P.R., Storm G., van Nostrum C.F., Hennink W.E. Superparamagnetic iron oxide nanoparticles encapsulated in biodegradable thermosensitive polymeric micelles: toward a targeted nanomedicine suitable for image-guided drug delivery. Langmuir 2009, 25:2060-2067.
223. Bakandritsos A., Mattheolabakis G., Zboril R., Bouropoulos N., Tucek J., Fatouros D.G., Avgoustakis K. Preparation, stability and cytocompatibility of magnetic/PLA-PEG hybrids. Nanoscale 2010, 2:564-572.
224. Kim D.H., Vitol E.A., Liu J., Balasubramanian S., Gosztola D.J., Cohen E.E., Novosad V., Rozhkova E.A. Stimuli-responsive magnetic nanomicelles as multifunctional heat and cargo delivery vehicles. Langmuir 2013, 29:7425-7432.
225. Peng H., Blakey I., Dargaville B., Rasoul F., Rose S., Whittaker A.K. Synthesis and evaluation of partly fluorinated block copolymers as MRI imaging agents. Biomacromolecules 2009, 10:374-381.
226. Oishi M., Sumitani S., Nagasaki Y. On-off regulation of 19F magnetic resonance signals based on pH-sensitive PEGylated nanogels for potential tumor-specific smart 19F MRI probes. Bioconjug. Chem. 2007, 18:1379-1382.
227. Matsumoto Y., Nomoto T., Cabral H., Matsumoto Y., Watanabe S., Christie R.J., Miyata K., Oba M., Ogura T., Yamasaki Y., Nishiyama N., Yamasoba T., Kataoka K. Direct and instantaneous observation of intravenously injected substances using intravital confocal micro-videography. Biomed. Opt. Express 2010, 1:1209-1216.
228. Mulder W.J., Koole R., Brandwijk R.J., Storm G., Chin P.T., Strijkers G.J., de Mello Donega C., Nicolay K., Griffioen A.W. Quantum dots with a paramagnetic coating as a bimodal molecular imaging probe. Nano Lett. 2006, 6:1-6.
229. Liu L., Law W.C., Yong K.T., Roy I., Ding H., Erogbogbo F., Zhang X., Prasad P.N. Multimodal imaging probes based on Gd-DOTA conjugated quantum dot nanomicelles. Analyst 2011, 136:1881-1886.
230. Howes P., Green M., Bowers A., Parker D., Varma G., Kallumadil M., Hughes M., Warley A., Brain A., Botnar R. Magnetic conjugated polymer nanoparticles as bimodal imaging agents. J. Am. Chem. Soc. 2010, 132:9833-9842.
231. Cha E.J., Jang E.S., Sun I.C., Lee I.J., Ko J.H., Kim Y.I., Kwon I.C., Kim K., Ahn C.H. Development of MRI/NIRF 'activatable' multimodal imaging probe based on iron oxide nanoparticles. J. Control. Release 2011, 155:152-158.
232. He X., Wang K., Cheng Z. In vivo near-infrared fluorescence imaging of cancer with nanoparticle-based probes. Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol. 2010, 2:349-366.
233. Rao J., Dragulescu-Andrasi A., Yao H. Fluorescence imaging in vivo: recent advances. Curr. Opin. Biotechnol. 2007, 18:17-25.
234. Michalet X., Pinaud F.F., Bentolila L.A., Tsay J.M., Doose S., Li J.J., Sundaresan G., Wu A.M., Gambhir S.S., Weiss S. Quantum dots for live cells, in vivo imaging, and diagnostics. Science 2005, 307:538-544.
235. Ji X., Palui G., Avellini T., Na H.B., Yi C., Knappenberger K.L., Mattoussi H. On the pH-dependent quenching of quantum dot photoluminescence by redox active dopamine. J. Am. Chem. Soc. 2012, 134:6006-6017.
236. Hu J., Liu T., Zhang G., Jin F., Liu S. Synergistically enhance magnetic resonance/fluorescence imaging performance of responsive polymeric nanoparticles under mildly acidic biological milieu. Macromol. Rapid Commun. 2013, 34:749-758.
237. Gao G.H., Heo H., Lee J.H., Lee D.S. An acidic pH-triggered polymeric micelle for dual-modality MR and optical imaging. J. Mater. Chem. 2010, 20:5454-5461.
238. Glaus C., Rossin R., Welch M.J., Bao G. In vivo evaluation of (64)Cu-labeled magnetic nanoparticles as a dual-modality PET/MR imaging agent. Bioconjug. Chem. 2010, 21:715-722.
239. Locatelli E., Gil L., Israel L.L., Passoni L., Naddaka M., Pucci A., Reese T., Gomez-Vallejo V., Milani P., Matteoli M., Llop J., Lellouche J.P., Franchini M.C. Biocompatible nanocomposite for PET/MRI hybrid imaging. Int. J. Nanomedicine 2012, 7:6021-6033.
240. Howell M., Mallela J., Wang C., Ravi S., Dixit S., Garapati U., Mohapatra S. Manganese-loaded lipid-micellar theranostics for simultaneous drug and gene delivery to lungs. J. Control. Release 2013, 167:210-218.
241. Pan D., Caruthers S.D., Hu G., Senpan A., Scott M.J., Gaffney P.J., Wickline S.A., Lanza G.M. Ligand-directed nanobialys as theranostic agent for drug delivery and manganese-based magnetic resonance imaging of vascular targets. J. Am. Chem. Soc. 2008, 130:9186-9187.
242. Yu M.K., Jeong Y.Y., Park J., Park S., Kim J.W., Min J.J., Kim K., Jon S. Drug-loaded superparamagnetic iron oxide nanoparticles for combined cancer imaging and therapy in vivo. Angew. Chem. 2008, 47:5362-5365.
243. Nasongkla N., Bey E., Ren J., Ai H., Khemtong C., Guthi J.S., Chin S.F., Sherry A.D., Boothman D.A., Gao J. Multifunctional polymeric micelles as cancer-targeted, MRI-ultrasensitive drug delivery systems. Nano Lett. 2006, 6:2427-2430.
244. Zou P., Yu Y., Wang Y.A., Zhong Y., Welton A., Galban C., Wang S., Sun D. Superparamagnetic iron oxide nanotheranostics for targeted cancer cell imaging and pH-dependent intracellular drug release. Mol. Pharm. 2010, 7:1974-1984.
245. Sun C., Veiseh O., Gunn J., Fang C., Hansen S., Lee D., Sze R., Ellenbogen R.G., Olson J., Zhang M. In vivo MRI detection of gliomas by chlorotoxin-conjugated superparamagnetic nanoprobes. Small 2008, 4:372-379.
246. Koo H., Lee H., Lee S., Min K.H., Kim M.S., Lee D.S., Choi Y., Kwon I.C., Kim K., Jeong S.Y. In vivo tumor diagnosis and photodynamic therapy via tumoral pH-responsive polymeric micelles. Chem. Commun. (Camb.) 2010, 46:5668-5670.
247. Wang C., Ravi S., Martinez G.V., Chinnasamy V., Raulji P., Howell M., Davis Y., Mallela J., Seehra M.S., Mohapatra S. Dual-purpose magnetic micelles for MRI and gene delivery. J. Control. Release 2012, 163:82-92.
248. Chen Y., Lian G., Liao C., Wang W., Zeng L., Qian C., Huang K., Shuai X. Characterization of polyethylene glycol-grafted polyethylenimine and superparamagnetic iron oxide nanoparticles (PEG-g-PEI-SPION) as an MRI-visible vector for siRNA delivery in gastric cancer in vitro and in vivo. J. Gastroenterol. 2013, 48:809-821.
249. Chen Y., Wang W., Lian G., Qian C., Wang L., Zeng L., Liao C., Liang B., Huang B., Huang K., Shuai X. Development of an MRI-visible nonviral vector for siRNA delivery targeting gastric cancer. Int. J. Nanomedicine 2012, 7:359-368.
250. Porsch C., Zhang Y., Ostlund A., Damberg P., Ducani C., Malmström E., Nyström A.M. In vitro evaluation of non-protein adsorbing breast cancer theranostics based on 19F-polymer containing nanoparticles. Part. Part. Syst. Charact. 2013, 30:381-390.
251. Cheng F.Y., Wang S.P., Su C.H., Tsai T.L., Wu P.C., Shieh D.B., Chen J.H., Hsieh P.C., Yeh C.S. Stabilizer-free poly(lactide-co-glycolide) nanoparticles for multimodal biomedical probes. Biomaterials 2008, 29:2104-2112.
252. Niu C., Wang Z., Lu G., Krupka T.M., Sun Y., You Y., Song W., Ran H., Li P., Zheng Y. Doxorubicin loaded superparamagnetic PLGA-iron oxide multifunctional microbubbles for dual-mode US/MR imaging and therapy of metastasis in lymph nodes. Biomaterials 2013, 34:2307-2317.
253. Ratzinger G., Agrawal P., Korner W., Lonkai J., Sanders H.M., Terreno E., Wirth M., Strijkers G.J., Nicolay K., Gabor F. Surface modification of PLGA nanospheres with Gd-DTPA and Gd-DOTA for high-relaxivity MRI contrast agents. Biomaterials 2010, 31:8716-8723.
254. Vivero-Escoto J.L., Huxford-Phillips R.C., Lin W. Silica-based nanoprobes for biomedical imaging and theranostic applications. Chem. Soc. Rev. 2012, 41:2673-2685.
255. Rieter W.J., Kim J.S., Taylor K.M., An H., Lin W., Tarrant T., Lin W. Hybrid silica nanoparticles for multimodal imaging. Angew. Chem. 2007, 46:3680-3682.
256. Taylor K.M., Kim J.S., Rieter W.J., An H., Lin W., Lin W. Mesoporous silica nanospheres as highly efficient MRI contrast agents. J. Am. Chem. Soc. 2008, 130:2154-2155.
257. Kim J., Kim H.S., Lee N., Kim T., Kim H., Yu T., Song I.C., Moon W.K., Hyeon T. Multifunctional uniform nanoparticles composed of a magnetite nanocrystal core and a mesoporous silica shell for magnetic resonance and fluorescence imaging and for drug delivery. Angew. Chem. 2008, 47:8438-8441.
258. Tanaka K., Kitamura N., Naka K., Morita M., Inubushi T., Chujo M., Nagao M., Chujo Y. Improving proton relaxivity of dendritic MRI contrast agents by rigid silsesquioxane core. Polym. J. 2009, 41:287-292.
259. Meade T.J., Taylor A.K., Bull S.R. New magnetic resonance contrast agents as biochemical reporters. Curr. Opin. Neurobiol. 2003, 13:597-602.
260. Louie A.Y., Huber M.M., Ahrens E.T., Rothbacher U., Moats R., Jacobs R.E., Fraser S.E., Meade T.J. In vivo visualization of gene expression using magnetic resonance imaging. Nat. Biotechnol. 2000, 18:321-325.
261. Li W.H., Parigi G., Fragai M., Luchinat C., Meade T.J. Mechanistic studies of a calcium-dependent MRI contrast agent. Inorg. Chem. 2002, 41:4018-4024.
262. Zhang S., Wu K., Sherry A.D. A novel pH-sensitive MRI contrast agent. Angew. Chem. 1999, 38:3192-3194.
263. Aime S., Delli Castelli D., Terreno E. Novel pH-reporter MRI contrast agents. Angew. Chem. 2002, 41:4334-4336.
264. Osborne E.A., Jarrett B.R., Tu C., Louie A.Y. Modulation of T2 relaxation time by light-induced, reversible aggregation of magnetic nanoparticles. J. Am. Chem. Soc. 2010, 132:5934-5935.
265. Clavijo Jordan V., Baldelomar E., Beeman S.C., Bennett K.M. Disruptive chemical doping in a ferritin-based iron oxide nanoparticle to decrease r2 and enhance detection with T1-weighted MRI. Contrast Media Mol. Imaging 2014, (in press).
266. Zabow G., Dodd S., Moreland J., Koretsky A. Micro-engineered local field control for high-sensitivity multispectral MRI. Nature 2008, 453:1058-1063.
267. Gleich B., Weizenecker J. Tomographic imaging using the nonlinear response of magnetic particles. Nature 2005, 435:1214-1217.
268. Yallapu M.M., Othman S.F., Curtis E.T., Gupta B.K., Jaggi M., Chauhan S.C. Multi-functional magnetic nanoparticles for magnetic resonance imaging and cancer therapy. Biomaterials 2011, 32:1890-1905.
269. Sonoda A., Nitta N., Ohta S., Seko A., Jo J., Morikawa S., Tabata Y., Takahashi M., Murata K. Development of a conjugated gadolinium and cisplatin-gelatin possessing properties as an intravascular contrast agent for MR imaging. Eur. J. Radiol. 2009, 71:570-575.
270. Vaidya A., Sun Y., Feng Y., Emerson L., Jeong E.K., Lu Z.R. Contrast-enhanced MRI-guided photodynamic cancer therapy with a pegylated bifunctional polymer conjugate. Pharm. Res. 2008, 25:2002-2011.
271. Akiyoshi K., Kobayashi S., Shichibe S., Mix D., Baudys M., Kim S.W., Sunamoto J. Self-assembled hydrogel nanoparticle of cholesterol-bearing pullulan as a carrier of protein drugs: complexation and stabilization of insulin. J. Control. Release 1998, 54:313-320.
272. Murayama S., Su B., Okabe K., Kishimura A., Osada K., Miura M., Funatsu T., Kataoka K., Kato M. NanoPARCEL: a method for controlling cellular behavior with external light. Chem. Commun. (Camb.) 2012, 48:8380-8382.
273. Murayama S., Jo J.-i., Shibata Y., Liang K., Santa T., Saga T., Aoki I., Kato M. The simple preparation of polyethylene glycol-based soft nanoparticles containing dual imaging probes. J. Mater. Chem. B 2013, 1:4932-4938.
274. Lee J., Kim K., Park W.I., Kim B.H., Park J.H., Kim T.H., Bong S., Kim C.H., Chae G., Jun M., Hwang Y., Jung Y.S., Jeon S. Uniform graphene quantum dots patterned from self-assembled silica nanodots. Nano Lett. 2012, 12:6078-6083.
275. Kenny G.D., Kamaly N., Kalber T.L., Brody L.P., Sahuri M., Shamsaei E., Miller A.D., Bell J.D. Novel multifunctional nanoparticle mediates siRNA tumour delivery, visualisation and therapeutic tumour reduction in vivo. J. Control. Release 2011, 149:111-116.
276. Tabata Y., Murakami Y., Ikada Y. Photodynamic effect of polyethylene glycol-modified fullerene on tumor. Jpn. J. Cancer Res. 1997, 88:1108-1116.
277. Arbogast J., Darmanyan A., Foote C., Rubin Y., Diederich F., Alvarez M., Anz S., Whetten R. Photophysical properties of sixty atom carbon molecule (C60). J. Phys. Chem. 1991, 95:11-12.
278. Yumita N., Nishigaki R., Umemura K., Umemura S. Hematoporphyrin as a sensitizer of cell-damaging effect of ultrasound. Jpn. J. Cancer Res. 1989, 80:219-222.
279. Feril L., Kondo T., Umemura S., Tachibana K., Manalo A., Riesz P. Sound waves and antineoplastic drugs: the possibility of an enhanced combined anticancer therapy. J. Med. Ultrason. 2002, 29:173-187.
280. Bhave G., Lewis J.B., Chang S.S. Association of gadolinium based magnetic resonance imaging contrast agents and nephrogenic systemic fibrosis. J. Urol. 2008, 180:830-835. (discussion 835).
281. Fatouros P.P., Corwin F.D., Chen Z.J., Broaddus W.C., Tatum J.L., Kettenmann B., Ge Z., Gibson H.W., Russ J.L., Leonard A.P., Duchamp J.C., Dorn H.C. In vitro and in vivo imaging studies of a new endohedral metallofullerene nanoparticle. Radiology 2006, 240:756-764.
282. Bolskar R.D. Gadofullerene MRI contrast agents. Nanomedicine (Lond) 2008, 3:201-213.
283. Anderson S.A., Lee K.K., Frank J.A. Gadolinium-fullerenol as a paramagnetic contrast agent for cellular imaging. Invest. Radiol. 2006, 41:332-338.
284. Toth E., Bolskar R.D., Borel A., Gonzalez G., Helm L., Merbach A.E., Sitharaman B., Wilson L.J. Water-soluble gadofullerenes: toward high-relaxivity, pH-responsive MRI contrast agents. J. Am. Chem. Soc. 2005, 127:799-805.
285. Sugita N., Kawabata K., Sasaki K., Sakata I., Umemura S. Synthesis of amphiphilic derivatives of rose bengal and their tumor accumulation. Bioconjug. Chem. 2007, 18:866-873.
286. Razum N., Balchum O.J., Profio A.E., Carstens F. Skin photosensitivity: duration and intensity following intravenous hematoporphyrin derivates, HpD and DHE. Photochem. Photobiol. 1987, 46:925-928.
287. Kato D., Niwa O. Carbon-based electrode materials for DNA electroanalysis. Anal. Sci. 2013, 29:385-392.
288. Dey R.S., Bera R.K., Raj C.R. Nanomaterial-based functional scaffolds for amperometric sensing of bioanalytes. Anal. Bioanal. Chem. 2013, 405:3431-3448.
289. Delogu L.G., Vidili G., Venturelli E., Menard-Moyon C., Zoroddu M.A., Pilo G., Nicolussi P., Ligios C., Bedognetti D., Sgarrella F., Manetti R., Bianco A. Functionalized multiwalled carbon nanotubes as ultrasound contrast agents. Proc. Natl. Acad. Sci. U. S. A. 2012, 109:16612-16617.
290. Liu Z., Liang X.J. Nano-carbons as theranostics. Theranostics 2012, 2:235-237.
291. Wang X., Wang C., Cheng L., Lee S.T., Liu Z. Noble metal coated single-walled carbon nanotubes for applications in surface enhanced Raman scattering imaging and photothermal therapy. J. Am. Chem. Soc. 2012, 134:7414-7422.
292. Choi K.Y., Liu G., Lee S., Chen X. Theranostic nanoplatforms for simultaneous cancer imaging and therapy: current approaches and future perspectives. Nanoscale 2012, 4:330-342.
293. Chouikrat R., Seve A., Vanderesse R., Benachour H., Barberi-Heyob M., Richeter S., Raehm L., Durand J.O., Verelst M., Frochot C. Non polymeric nanoparticles for photodynamic therapy applications: recent developments. Curr. Med. Chem. 2012, 19:781-792.
294. Fernandez-Fernandez A., Manchanda R., McGoron A.J. Theranostic applications of nanomaterials in cancer: drug delivery, image-guided therapy, and multifunctional platforms. Appl. Biochem. Biotechnol. 2011, 165:1628-1651.
295. Yang S.T., Luo J., Zhou Q., Wang H. Pharmacokinetics, metabolism and toxicity of carbon nanotubes for biomedical purposes. Theranostics 2012, 2:271-282.
296. Yang K., Wan J., Zhang S., Tian B., Zhang Y., Liu Z. The influence of surface chemistry and size of nanoscale graphene oxide on photothermal therapy of cancer using ultra-low laser power. Biomaterials 2012, 33:2206-2214.
297. Yang K., Zhang S., Zhang G., Sun X., Lee S.T., Liu Z. Graphene in mice: ultrahigh in vivo tumor uptake and efficient photothermal therapy. Nano Lett. 2010, 10:3318-3323.
298. Liu X., Tao H., Yang K., Zhang S., Lee S.T., Liu Z. Optimization of surface chemistry on single-walled carbon nanotubes for in vivo photothermal ablation of tumors. Biomaterials 2011, 32:144-151.
299. 3+ chelates: toward powerful T1 and T2 MRI contrast agents. Nano Lett. 2008, 8:232-236.
300. Lamanna G., Garofalo A., Popa G., Wilhelm C., Begin-Colin S., Felder-Flesch D., Bianco A., Gazeau F., Menard-Moyon C. Endowing carbon nanotubes with superparamagnetic properties: applications for cell labeling, MRI cell tracking and magnetic manipulations. Nanoscale 2013, 5:4412-4421.
301. Hobbs S.K., Monsky W.L., Yuan F., Roberts W.G., Griffith L., Torchilin V.P., Jain R.K. Regulation of transport pathways in tumor vessels: role of tumor type and microenvironment. Proc. Natl. Acad. Sci. U. S. A. 1998, 95:4607-4612.
302. Correas J.M., Bridal L., Lesavre A., Mejean A., Claudon M., Helenon O. Ultrasound contrast agents: properties, principles of action, tolerance, and artifacts. Eur. Radiol. 2001, 11:1316-1328.
303. Singh R., Pantarotto D., Lacerda L., Pastorin G., Klumpp C., Prato M., Bianco A., Kostarelos K. Tissue biodistribution and blood clearance rates of intravenously administered carbon nanotube radiotracers. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:3357-3362.
304. Kostarelos K., Bianco A., Prato M. Promises, facts and challenges for carbon nanotubes in imaging and therapeutics. Nat. Nanotechnol. 2009, 4:627-633.
305. Liu Z., Tabakman S., Welsher K., Dai H. Carbon nanotubes in biology and medicine: in vitro and in vivo detection. Imaging Drug Deliv. Nano Res. 2009, 2:85-120.
306. Rapoport N., Gao Z., Kennedy A. Multifunctional nanoparticles for combining ultrasonic tumor imaging and targeted chemotherapy. J. Natl. Cancer Inst. 2007, 99:1095-1106.
307. Sanna V., Pintus G., Bandiera P., Anedda R., Punzoni S., Sanna B., Migaleddu V., Uzzau S., Sechi M. Development of polymeric microbubbles targeted to prostate-specific membrane antigen as prototype of novel ultrasound contrast agents. Mol. Pharm. 2011, 8:748-757.
308. Herrero M.A., Toma F.M., Al-Jamal K.T., Kostarelos K., Bianco A., Da Ros T., Bano F., Casalis L., Scoles G., Prato M. Synthesis and characterization of a carbon nanotube-dendron series for efficient siRNA delivery. J. Am. Chem. Soc. 2009, 131:9843-9848.
309. Liu Z., Chen K., Davis C., Sherlock S., Cao Q., Chen X., Dai H. Drug delivery with carbon nanotubes for in vivo cancer treatment. Cancer Res. 2008, 68:6652-6660.
310. Liu Z., Davis C., Cai W., He L., Chen X., Dai H. Circulation and long-term fate of functionalized, biocompatible single-walled carbon nanotubes in mice probed by Raman spectroscopy. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:1410-1415.
311. Hong H., Gao T., Cai W. Molecular imaging with single-walled carbon nanotubes. Nano Today 2009, 4:252-261.
312. de la Zerda A., Liu Z., Bodapati S., Teed R., Vaithilingam S., Khuri-Yakub B.T., Chen X., Dai H., Gambhir S.S. Ultrahigh sensitivity carbon nanotube agents for photoacoustic molecular imaging in living mice. Nano Lett. 2010, 10:2168-2172.
313. De la Zerda A., Zavaleta C., Keren S., Vaithilingam S., Bodapati S., Liu Z., Levi J., Smith B.R., Ma T.J., Oralkan O., Cheng Z., Chen X., Dai H., Khuri-Yakub B.T., Gambhir S.S. Carbon nanotubes as photoacoustic molecular imaging agents in living mice. Nat. Nanotechnol. 2008, 3:557-562.
314. Wang L.V., Hu S. Photoacoustic tomography: in vivo imaging from organelles to organs. Science 2012, 335:1458-1462.
315. Moon H.K., Lee S.H., Choi H.C. In vivo near-infrared mediated tumor destruction by photothermal effect of carbon nanotubes. ACS Nano 2009, 3:3707-3713.
316. Liu Z., Cai W., He L., Nakayama N., Chen K., Sun X., Chen X., Dai H. In vivo biodistribution and highly efficient tumour targeting of carbon nanotubes in mice. Nat. Nanotechnol. 2007, 2:47-52.
317. Kageyama S., Kitano S., Hirayama M., Nagata Y., Imai H., Shiraishi T., Akiyoshi K., Scott A.M., Murphy R., Hoffman E.W., Old L.J., Katayama N., Shiku H. Humoral immune responses in patients vaccinated with 1-146 HER2 protein complexed with cholesteryl pullulan nanogel. Cancer Sci. 2008, 99:601-607.
318. Nochi T., Yuki Y., Takahashi H., Sawada S., Mejima M., Kohda T., Harada N., Kong I.G., Sato A., Kataoka N., Tokuhara D., Kurokawa S., Takahashi Y., Tsukada H., Kozaki S., Akiyoshi K., Kiyono H. Nanogel antigenic protein-delivery system for adjuvant-free intranasal vaccines. Nat. Mater. 2010, 9:572-578.